相关实验视频
Updated: Jul 23, 2025
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.5K
血小板衍生微粒通过代谢重编程引起慢性淋巴细胞白血病恶性瘤
Ehsan Gharib1,2,3, Vanessa Veilleux1,2,3, Luc H Boudreau1,3
1Department of Chemistry and Biochemistry, Université de Moncton, Moncton, NB, Canada.
Frontiers in immunology
|July 13, 2023
概括
血小板衍生微粒 (PMP) 将线粒体转移到慢性淋巴细胞白血病 (CLL) 细胞,推动癌症的进展和化学抵抗. 这项研究揭示了一种新的血小板驱动的机制,用于癌症病原和CLL的进展.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 血小板和炎症是已知的癌症恶性病变的驱动因素.
- 血小板衍生微粒 (PMP) 将生物载荷,包括功能性线粒体,转移到癌细胞.
- 线粒体转移影响癌症的特征,如生长,亡抑制和耐药性,特别是在慢性淋巴细胞白血病 (CLL) 中.
研究的目的:
- 调查PMPs在调节CLL细胞代谢可塑性的作用.
- 了解PMP诱导的代谢变化如何影响癌细胞表型和疾病进展.
主要方法:
- 用人类PMP化了CLL细胞系,以评估扩散,线粒体DNA拷贝数,氧消耗率 (OCR),ATP生产和活性氧物种 (ROS) 含量.
- 生物信息学工具在早期和晚期的CLL阶段确定了关键的代谢重编程基因,在PMP治疗的CLL中得到验证.
- 代谢重编程对CLL生长,生存,移动性和侵入性的影响与Cytarabine,Venetoclax和Plumbagin进行了测试.
主要成果:
- 通过线粒体内化和OXPHOS刺激,PMPs显著诱导了CLL中的瘤生长和侵入性.
- 在PMP治疗的CLL中观察到的代谢变化与晚期CLL患者的代谢变化相似.
- 代谢重新连接增强了CLL细胞对Cytarabine,Venetoclax和Plumbagin的抵抗力.
结论:
- PMPs在癌症发病过程中代表了一种新的血小板媒介途径.
- 孕产妇预防药物在CLL代谢重编程中发挥着关键作用,推动疾病的进展和化疗抵抗.
更多相关视频
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.1K
11:39Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
Published on: October 23, 2019
11.5K
相关概念视频
01:27Disorders of Leukocytes
984
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
984
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K